These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19345816)

  • 1. Lipid lowering for primary prevention.
    Yusuf S; Lonn E; Bosch J
    Lancet; 2009 Apr; 373(9670):1152-5. PubMed ID: 19345816
    [No Abstract]   [Full Text] [Related]  

  • 2. The JUPITER Trial: responding to the critics.
    Ridker PM; Glynn RJ
    Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comment from the lipidologic viewpoint].
    Riesen WF
    Praxis (Bern 1994); 2009 Feb; 98(3):125-7. PubMed ID: 19180437
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comment from the family practice viewpoint].
    Coradi B
    Praxis (Bern 1994); 2009 Feb; 98(3):131. PubMed ID: 19180439
    [No Abstract]   [Full Text] [Related]  

  • 5. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 6. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
    Duvernoy CS; Blumenthal R
    Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
    [No Abstract]   [Full Text] [Related]  

  • 7. Study stirs debate about statin use in those without high cholesterol.
    Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535
    [No Abstract]   [Full Text] [Related]  

  • 8. Is Jupiter also a god of primary prevention?
    Accad M; Fred HL
    Tex Heart Inst J; 2010; 37(1):6-7. PubMed ID: 20200621
    [No Abstract]   [Full Text] [Related]  

  • 9. Bringing JUPITER down to earth.
    Després JP
    Lancet; 2009 Apr; 373(9670):1147-8. PubMed ID: 19329179
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
    Nicholls SJ; Uno K; Kataoka Y
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1383-90. PubMed ID: 22059787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.
    Ann Intern Med; 2010 Apr; 152(8):I34. PubMed ID: 20404365
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid lowering by rosuvastatin: how do statins differ?].
    Laufs U
    Dtsch Med Wochenschr; 2015 Mar; 140(5):313. PubMed ID: 25734669
    [No Abstract]   [Full Text] [Related]  

  • 13. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 14. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
    Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Segura J; Ruilope LM
    Lancet; 2009 Jul; 374(9683):26; author reply 26-7. PubMed ID: 19577691
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
    Couzin J
    Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Sniderman AD
    Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690
    [No Abstract]   [Full Text] [Related]  

  • 18. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Feeman WE
    Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577687
    [No Abstract]   [Full Text] [Related]  

  • 19. Jupiter to Earth: CRP promotes atherothrombosis.
    Jialal I; Devaraj S
    Metab Syndr Relat Disord; 2009 Feb; 7(1):1-3. PubMed ID: 19183073
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
    Ridker PM;
    Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.